Regenerative Medicine Market Expected to Gain a Valuation of US$12.9 Billion by 2028, According to State TMR Study

ALBANY, NY, February 17, 2022 /PRNewswire/ — The global regenerative medicine market is expected to grow at a CAGR of 10.3% during the forecast period of 2021 to 2028, notes a research report by Transparency Market Research (TMR).

Regenerative medicine is gaining momentum in the healthcare industry, owing to its ability to provide different cell therapies and related products, including natural killer (NK) cell therapy, stem cell therapy, exosomes, tissue products and the chimeric antigen receptor (CAR) T cell therapy.

Request Regenerative Medicine Market Research Report Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=419

Players operating in the global regenerative medicine market are sensitizing the patient group about the various advantages as well as disadvantages of regenerative medicines. These efforts help companies improve clinical outcomes. At the same time, such initiatives enable patients to make informed decisions about their treatments, notes a TMR study on the global regenerative medicine market.

The concept of regenerative medicines is relatively new. Hence, companies operating in the global regenerative medicine market are increasing their revenue for advertising and marketing activities. For example, several companies are developing stands that can be placed in hospitals in order to increase the visibility of their products, thereby increasing awareness about regenerative medicines. With these efforts, the global regenerative medicine market is expected to gain a value of US$12.9 billion by 2028, say TMR analysts.

Demand for Analysis of Impact of COVID-19 on Regenerative Medicine Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=419

Regenerative Medicine Market: Key Findings

  • Companies operating in the global regenerative medicine market are increasing their investments in R&D activities focused on developing highly effective products capable of preventing different complications in patients. These efforts help companies maintain their dominant position in the regenerative medicine market.
  • Generally, the elderly population is at higher risk for internal and external injuries, including joint and bone injuries. Hence, companies operating in the global regenerative medicine market are expected to gain significant business prospects with the increasing elderly population in the world.

Inquire Before You Buy – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=419

Regenerative Medicine Market: Growth Boosters

  • Rising cases of genetic diseases, cancers and chronic diseases across the world are opening promising business prospects in the regenerative medicine market
  • Technological advancements in stem cell therapy are expected to contribute to the expansion of the global regenerative medicine market in the coming years

Regenerative Medicine Market: Regional Analysis

  • the North America The regenerative medicine market is estimated to maintain its dominant position during the forecast period, owing to the increase in R&D activities performed in the United States. Additionally, the regional market is driven by an increase in investments from governments as well as private players operating in North America. In addition, the increase in the number of elderly people, who are more prone to different joint and bone problems, creates income-generating opportunities in the North America regenerative medicine market.
  • The regenerative medicine market is expected to gain lucrative prospects in Asia Pacific, due to the presence of a large patient base, improved healthcare infrastructure and increased understanding of regenerative medicines. Moreover, the Asia Pacific According to the TMR study, the market is expected to witness significant growth in sales owing to the improvement in the healthcare expenditure of the regional population.

Request a sample report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=419

Regenerative Medicine Market: Key Players

Some of the key players profiled in the report are:

  • Anika Therapeutics, Inc.
  • Smith & Nephew plc
  • Baxter International, Inc.
  • DePuy Synthes, Inc.
  • Medtronic, Inc.
  • Stryker Company
  • Zimmer Holdings, Inc.
  • CONMED Company
  • Arthrex, Inc.

Segmentation of the regenerative medicine market

Technology

  • Biomaterials
  • Stem cells
  • Creation of fabrics

Application

  • Bone graft substitutes
  • Osteoarticular diseases
  • Allogenic bones
  • Autogenous bones
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Modernization of healthcare in terms of infrastructure and services has pushed the healthcare industry to new heights, stay updated with Latest Health Industry Research Reports by Transparency Market Research:

Asthma Spacers Market: The global Asthma Spacers market was valued at US$1,330.56 million in 2017 and is expected to grow at a CAGR of 3.7% during the forecast period from 2018 to 2026. The global asthma spacers market is expected to be driven by advancements in technology and increasing usage of spacers with metered dose inhalers for the management of asthma.

Medical Imaging Phantoms Market: The global medical imaging phantoms market was valued at US$131.2 million in 2017 and is expected to grow at a CAGR of 3.6% from 2018 to 2026. Improving medical imaging using medical phantoms, reducing radiation exposure and increasing the efficiency of medical devices, along with increase in adoption of advanced imaging methods is expected to propel the global market from 2018 to 2026.

Gene Therapy Market: Approvals of new products, promising therapeutic results of gene therapy, and high prevalence of non-Hodgkin’s lymphoma are expected to drive the global market over the coming years. Europe is expected to dominate the global gene therapy market, followed by the United States, by the end of 2026.

About Us

Transparency Market Research is a global market intelligence company, providing global market intelligence reports and services. Our proprietary blend of quantitative forecasting and trend analysis delivers forward-looking insights to thousands of decision makers. Our experienced team of analysts, researchers and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With broad research and analytical capability, Transparency Market Research uses rigorous primary and secondary research techniques to develop distinctive datasets and research material for trade reports.

For more information on research on leading industries, visit our YouTube channel and click subscribe for future update – https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Mr. Rohit Bhisey
Transparency Market Research
state tower,
90 State Street,
Office 700,
Albany NY – 12207
United States
United States – Canada Toll Free: 866-552-3453
E-mail: [email protected]
follow us: Twitter | LinkedIn
Blog: https://tmrblog.com
Browse RP – https://www.transparencymarketresearch.com/pressrelease/regenerative-medicines-market.htm

SOURCE Transparency Market Research

More Stories
US pipeline company suspends operations after cyberattack